Acute thrombocytopenia after initiating anticoagulation with rivaroxaban

Yohei Mima, Yuhei Sangatsuda, Masahiro Yasaka, Yoshiyuki Wakugawa, Shinji Nagata, Yasushi Okada

研究成果: Contribution to journalArticle査読

11 被引用数 (Scopus)

抄録

A 75-year-old man with paroxysmal atrial fibrillation developed a traumatic intracranial hemorrhage during warfarin treatment. The administration of warfarin was stopped and rivaroxaban therapy, a novel oral anticoagulant (NOAC), was started. Immediately, his platelet count decreased to 3.7×104/μL. The platelet count recovered rapidly after cessation of rivaroxaban administration. Development of thrombocytopenia and its rapid recovery was observed again after another administration, and subsequent cessation, of the drug. A diagnosis of rivaroxaban-induced thrombocytopenia was made. The incidence of thrombocytopenia due to NOACs is rare. Careful attention to thrombocytopenia, which is associated with a higher risk for life-threatening bleeding, is therefore necessary during treatment with NOACs.

本文言語英語
ページ(範囲)2523-2527
ページ数5
ジャーナルInternal Medicine
53
21
DOI
出版ステータス出版済み - 2014
外部発表はい

All Science Journal Classification (ASJC) codes

  • 内科学

フィンガープリント

「Acute thrombocytopenia after initiating anticoagulation with rivaroxaban」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル